What is Global Peanut Allergy Treatment Market?
The Global Peanut Allergy Treatment Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. This market is primarily driven by the increasing prevalence of peanut allergies worldwide. Peanut allergy is one of the most common food allergies and can cause severe, potentially fatal, allergic reactions, including anaphylaxis. The treatment for this allergy is mainly focused on avoiding peanuts, managing symptoms, and in severe cases, treating anaphylaxis with epinephrine. However, recent advancements in medical research have led to the development of new therapies that can potentially desensitize individuals to peanuts, thereby reducing the risk of severe allergic reactions. These treatments include oral immunotherapy, sublingual immunotherapy, and epicutaneous immunotherapy. The global market for peanut allergy treatment is expected to grow significantly in the coming years due to the increasing demand for these new treatments. However, the high cost of these therapies and the lack of awareness about them in developing countries may hinder the market growth.
Oral, Injectable in the Global Peanut Allergy Treatment Market:
The Global Peanut Allergy Treatment Market is segmented based on the type of treatment, such as oral and injectable. Oral treatments include oral immunotherapy (OIT), where small amounts of peanut protein are ingested gradually increasing over time. This treatment aims to increase the threshold that triggers an allergic reaction. On the other hand, injectable treatments include epinephrine auto-injectors, which are used to treat severe allergic reactions, including anaphylaxis. These auto-injectors are portable and easy to use, making them a crucial part of emergency treatment for severe peanut allergies. The choice of treatment depends on the severity of the allergy, the patient's age, and their personal preference. Both these treatments have shown promising results in clinical trials, and their demand is expected to increase in the future. However, the high cost of these treatments and the risk of side effects may limit their use.
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Store, Others in the Global Peanut Allergy Treatment Market:
The Global Peanut Allergy Treatment Market also varies based on the distribution channel. These include retail pharmacies, hospital pharmacies, online pharmacies, drug stores, and others. Retail pharmacies are the most common distribution channel for peanut allergy treatments. They offer a wide range of products, including over-the-counter antihistamines and prescription medications. Hospital pharmacies also play a crucial role in providing emergency treatments for severe allergic reactions. Online pharmacies have gained popularity in recent years due to the convenience they offer. They provide easy access to medications, especially for people living in remote areas. Drug stores also offer a variety of allergy treatments, including epinephrine auto-injectors. Other distribution channels include clinics and health centers. The choice of distribution channel depends on factors such as the availability of products, the patient's convenience, and the cost of medications.
Global Peanut Allergy Treatment Market Outlook:
The Global Peanut Allergy Treatment Market outlook highlights that the market was valued at US$ 697.9 million in 2022. It is projected to reach a value of US$ 809.4 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period of 2023-2029. The United States is the largest consumer of peanut allergy treatments, accounting for nearly 45% of the global consumption in 2019. The market is dominated by key players such as Mylan, Bayer, UCB Pharma, J & J, and Perrigo, who collectively held a market share of 52%. The growth of the market is primarily driven by the increasing prevalence of peanut allergies and the development of new treatments. However, the high cost of these treatments and the lack of awareness in developing countries may limit the market growth.
| Report Metric | Details |
| Report Name | Peanut Allergy Treatment Market |
| Accounted market size in 2023 | US$ 697.9 million |
| Forecasted market size in 2029 | US$ 809.4 million |
| CAGR | 2.5 |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Pfizer, Sanofi, Mylan, Kaleo, Teva Pharmaceutical, Johnson＆Johnson, DBV Technologies, Aimmune Therapeutics, Prota Therapeutics |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
